BMAL1 and Parkinson disease: In comparison to controls, patients with PD had lower levels of circulating melatonin (p = 0.005), higher levels of cortisol (p = 0.0001), and altered Bmal1 expression (p = 0.004). Patients with PD also showed more fragmented motor activity over the course of 24 h and later sleep start time.